A clear next step for each stage of the Angelman journey
Families do not all need the same service. Some need to understand an old test. Some need to resolve a diagnostic gap. Others want an honest assessment of research possibilities. Begin with the smallest service that can answer the next important question.
| Service | Genetic Report Review | Research Feasibility Assessment | Staged Research Development | Funding and Partnership Planning |
|---|---|---|---|---|
| Best for | Families who have a genetic report and need to understand what was tested and what it means. | Families who want an honest scientific opinion before committing to laboratory work. | Families or partners with a defensible hypothesis ready for laboratory testing. | Families or organizations preparing a transparent funding proposal. |
| What you provide | Laboratory reports, consultation notes, and a short diagnostic timeline. | Full genetic report, clinical summary, desired research question, and constraints. | Approved feasibility assessment, hypothesis, and initial budget range. | Research plan, budget categories, milestones, and partnership goals. |
| What GeCure reviews | Test-method map, mechanism coverage, unresolved questions, and plain-language explanation. | Molecular mechanism, published evidence, models, delivery, safety, and competing research. | Candidate designs, assays, models, endpoints, risks, and milestones. | Budget structure, evidence package, governance, and possible funding routes. |
| What you receive | A structured review with discussion points and research-feasibility readiness status. | A go / revise / stop / prioritize-trial recommendation with rationale. | A milestone-based plan with decision gates, reporting schedule, and budget categories. | A milestone-based proposal for foundations, family fundraising, corporate partners, or collaborators. |
| Typical next decision | Whether to seek clarification from the original laboratory or proceed to feasibility assessment. | Whether to proceed to concept design, resolve a diagnostic gap, or stop. | Whether to fund and begin the next stage. | Which funding route to pursue first. |
| What is not included | A new clinical diagnosis, prescribing, guaranteed prognosis, or guaranteed trial eligibility. | A guarantee of success, clinical treatment, or regulatory approval. | A promise that the work will reach a clinical trial or benefit a specific person. | Guaranteed grants, insurance coverage, or donor commitments. |
| CTA | Start a report review | Request assessment | Explore research development | Explore funding |
What every family receives
- Respectful communication
- Plain-language summary
- Clear uncertainty
- Defined next decision
- No pressure to purchase the next stage
- Secure handling of sensitive documents
When GeCure may recommend not proceeding
- Diagnosis or mechanism is insufficiently defined
- The proposed target is not scientifically supported
- A current clinical trial is more relevant than a private R&D project
- A project duplicates available research without a clear advantage
- The requested outcome cannot be tested responsibly
- The expected cost is disproportionate to the evidence available
GeCure Solutions provides scientific review and research-development services. These services are not a substitute for medical diagnosis, clinical care, or advice from a licensed healthcare professional.
Choose the smallest step that answers your next question
You can begin with a document review. You do not need to commit to a research project.
Submitting an inquiry does not enroll anyone in research or guarantee acceptance.